Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.580
-0.060 (-1.29%)
May 20, 2026, 4:00 PM EDT - Market closed
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $53.3 million as of May 20, 2026. Its market cap has increased by 60.01% in one year.
Market Cap
53.30M
Enterprise Value
27.26M
1-Year Change
60.01%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $53.30M, a decrease of -26.83%. That is a compound annual growth rate of -6.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 53.30M | -9.82% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 57.49M |
| Cingulate | 56.72M |
| Instil Bio | 54.39M |
| Hyperion DeFi | 53.70M |
| MiNK Therapeutics | 53.41M |
| aTyr Pharma | 52.03M |
| Gossamer Bio | 50.53M |
| Xilio Therapeutics | 50.50M |